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Comparison of Conventional Cytogenetic and
Fluorescence In Situ Hybridization Results of Prenatal
Aneuploidy Screening
Background and Aim: Prenatal diagnosis of chromosome abnormalities is usually performed on amniotic
fluid samples. Aneuploidy screening by fluorescence in situ hybridization (FISH), although not an alternative
for conventional cytogenetics, has become a useful tool.
Materials and Methods: We compared the results of FISH and conventional cytogenetic analysis applied on
51 amniotic fluid samples between January 2002 and December 2005, in our Cytogenetics Laboratory.
Amniocytes were extracted using 5 cc of the sample, and direct FISH was applied using an AneuVysion Assay
Kit (Vysis). The remaining fluid samples were used for chromosome analysis by conventional methods after
long-term cell cultures.
Results: The results of both methods were compatible for 48 patients. For the 2 patients, although FISH
results were normal, structural abnormalities were detected by the conventional cytogenetic method. In one
patient, we detected mosaic trisomy 21 by FISH, whereas a 47,XX,+21 karyotype was identified in all cells
that were examined by the conventional cytogenetic method.
Conclusions: During genetic counseling, it is important to inform patients who undergo aneuploidy screening
by FISH about the advantages and disadvantages of the method to help them acknowledge the results in the
event that an abnormality is identified in the karyotype.
Key Words: Aneuploidy, prenatal diagnostic tests, FISH, conventional cytogenetics

Anöploidi Taramas›nda Konvansiyonel Sitogenetik ve Floresan ‹n Situ
Hibridizasyon Bulgular›n›n Karﬂ›laﬂt›r›lmas›
Giriﬂ ve Amaç: Amniyon s›v›s›ndan kromozom eldesi ve analizi, do¤um öncesinde kromozomal hastal›klar›n
tan›s›nda en s›k kullan›lan yöntemdir. Floresan in Situ Hibridizasyon (FISH) yöntemi ise konvansiyonel
sitogenetik için bir alternatif olmamakla birlikte yararl› bir tan› arac›d›r.
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Yöntem ve Gereç: Bu çal›ﬂmada 2002-2005 y›llar› aras›nda sitogenetik laboratuar›m›za anöploidi taramas›
için gönderilen 51 olgunun amniyon s›v›s› örnekleri üzerinde uygulanan FISH ve konvansiyonel sitogenetik
analiz sonuçlar› karﬂ›laﬂt›rmal› olarak de¤erlendirildi. Gönderilen materyalden her olguda 5 cc lik s›v› ayr›larak
amniyositler elde edildi ve bunlara Aneuvysion Assay Kit (Vysis) probu kullan›larak direkt FISH yöntemi
uyguland›. Kalan s›v› uzun dönem hücre kültürü sonras›nda konvansiyonel yöntemlerle kromozom eldesi için
kullan›ld›.
Bulgular: Sonuçlar karﬂ›laﬂt›r›ld›¤›nda, 48 hastada FISH ve konvansiyonel sitogenetik yöntem sonuçlar›
uyumlu bulundu. 2 hastada ise FISH ile anöploidi taramas› sonucu normal olarak de¤erlendirilmesine karﬂ›n
konvansiyonel sitogenetik yöntemle yap›sal anomali saptand›. Direk FISH yöntemi ile mozaik trizomi 21
saptanan bir hastada ise konvansiyonel sitogenetik yöntemle incelenen tüm hücrelerde 47,XX,+21 karyotipi
saptand›.
Sonuç: Sonuç olarak, FISH yöntemi kullan›larak anöploidi taramas› yap›lan hastalar›n genetik dan›ﬂma ile
yöntemin avantaj ve dezavantajlar› aç›s›ndan bilgilendirilmesi, karyotipte anormallik saptanmas› durumunda,
bulgular› kabullenmeleri aç›s›ndan önem taﬂ›maktad›r.
Anahtar Sözcükler: Anöploidi, prenatal tan› testleri, FISH, konvansiyonel sitogenetik
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Introduction
In every pregnancy, there is a risk of having an
aneuploid fetus. Twenty years ago, the extra risk beyond
the general risks was attributed to advanced maternal age
(AMA). Today, the values achieved from maternal serum
screenings and ultrasonographic examinations of the
fetus are also used effectively for the identification of
increased risks. The parameters utilized, on the one hand,
augment the false positivity in risk assessment, whereas,
on the other hand, they help determine other risky
situations the fetus might be in. In pregnancies in which
aneuploidy risk is identified, a common approach is to
obtain chromosomes from the amniotic fluid and to
analyze them. By this method, which can be applied
during the 16th-20th week of pregnancy, a diagnosis can
be reached by identifying the chromosomal set-up of the
fetus in 14-21 days. This period, which is necessary for
the diagnosis, can be very stressful for families who are
worried about the real risk, especially when the method
is applied in the later weeks of pregnancy and in cases of
high risk accompanied by abnormalities in fetal USG. In
applications of post-amniocentesis (AS) culture,
approximately 2% of the cultures are unsuccessful due to
cells that cannot adapt themselves to the environment
(1). In such a case, the family is informed, and either the
AS procedure is repeated or cordosynthesis (CS) is
applied. In overcoming such difficulties, aneuploidy
screening with FISH, the result of which can be obtained
in 3 days at most and which does not require
chromosome extraction, is crucial. In this method,
chromosomes 13, 18, 21, X and Y, which account for
80% of all aneuploidies, are evaluated quantitatively in
the nucleus. However, this research does not allow the
conducting of structural evaluation or assessments for
other chromosomal defects.
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screening test (DST), abnormalities in fetal USG (18),
advanced maternal age (AMA) (9), increased risk of DS
due to AMA + TST (4), and DS presence in the previous
child (2).
Conventional Cytogenetics: Five milliliters of each
amniotic fluid sample sent to our laboratory was kept in
sterile conditions for direct FISH. The remaining sample
was divided into 2; the cell suspension was added to
Amniomed (Biochrom, Germany) medium in 2 separate
flasks and they were left in a humid environment at 37 ºC
with 5% CO2 for long-term culture. On the first day, the
cultures were examined for viability and infection. On the
seventh day, the medium in the flasks was taken along
with the non-attached cells and added to a new flask, and
new medium was added to the first set of flasks. As the
colonization and mitotic activities of the cells became
adequate, chromosome harvesting by conventional
cytogenetic methods was performed, and the number and
structure of the chromosomes were analyzed by
conducting GTG and C banding, where necessary (2). The
karyotype was interpreted according to the International
System for Human Cytogenetic Nomenclature (ISCN,
2005) by analyzing at least 5 metaphases structurally and
20 metaphases numerically for each individual (3).
Molecular Cytogenetics: The cells were obtained
from the 5 ml aliquot of the amniotic fluid after
centrifugation.. They were prepared for direct FISH by
treatment with 1X Trypsin/EDTA, 75 mM KCl and
Carnoy’s fixative, respectively.

Materials and Methods

The fixed cells were spread on 2 separate microscope
slides. After being dried at room temperature, they were
kept in 1% pepsin solution for 20 min at 37 °C. Then
they were washed with distilled water and PBS solution,
kept in 2X SSC for 5 min, and washed with 70%, 85%,
and 90% ethyl alcohol, consecutively. The hybridization
was performed under the recommended conditions with
LSI 13/21 (Vysis, Aneuvysion, 32-161075) and CEP 18,
X, Y (Vysis, Aneuvysion, 32-161075) probe mixtures.
After hybridization, the slides were washed with the
recommended solutions, and DAPI-II was applied.

Patients: We included 51 cases that had been sent to
our laboratory between January 1, 2002, and December
31, 2005, for aneuploidy screening after amniocentesis
by conventional and molecular cytogenetic methods. The
indications were increased risk for Down Syndrome (DS)
(15) or trisomy 18 (T18) (1) in maternal serum triple
screening test (TST), increased T18 (2) risk by dual

For analysis, a minimum of 50 and a maximum of 100
nuclei were evaluated from each slide using the
appropriate probe filters. Cells that did not provide clear
signals were not taken into consideration. Identification
of 2% abnormal cells was considered false positive,
whereas identification of an abnormality rate of 15% or
above was considered true abnormality.

In the current study, we compared the conventional
and the molecular cytogenetic results of 51 cases referred
to our laboratory because of an increased aneuploidy risk.
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cytogenetic method. Among these 5 abnormalities, there
were T18s (2 cases), tiploidy (1 case), 47, XXY (1 case),
and T21 (1 case). Moreover, in one case, we identified a
marker chromosome, and, in another, we found an
increase in the centromeric heterochromatin of
chromosomes 15, which was considered a normal
variant. Mosaic trisomy 21 was determined by FISH in
the T21 case, while the conventional cytogenetic method
revealed an extra chromosome 21 in all metaphases.

Results
Findings regarding 51 cases that had been referred to
our laboratory for aneuploidy screening are given in Table.
One of our cases was a twin pregnancy (case numbers 19
and 20), while the others were single fetuses. Five cases
out of the 51 were diagnosed as aneuploidy (4 cases) and
euploidy (1 case) by FISH. In all of these cases,
aneuploidies were also determined by the conventional

Table. Indications and results of the patients.
Case No.

Age

Indication

Pregnancy week

Cytogenetic results

FISH results

1

28

TST/ DS

20

46,XX

N,XX

2

30

TST /DS

21

46,XX

N,XX

3

33

TST /DS

20

46,XY

N.XY

4

26

TST /DS

21, 4/7

46,XX

N,XX

5

33

TST /DS

19, 6/7

46,XY

N,XY

6

33

TST /DS

18, 4/7

47,XXY

N,XXY

7

30

TST /DS

18

46,XX

N.XX

8

29

TST /DS

17

46,XX,15cenh+pat

N,XX

9

34

TST /DS

17, 2/7

46,XX

N,XX

10

22

TST /DS

18, 1/7

46,XX

N,XX

11

34

TST /DS

18, 5/7

46,XX

N,XX

12

19

TST /DS

22

46,XX

N,XX

13

33

TST /DS

16, 2/7

46,XX

N,XX

14

27

TST /DS

21, 5/7

46,XY

N,XY

15

34

TST /DS

21

46,XX

N,XX

16

30

TST /T 18

18, 1/7

46,XY

N,XY

17

34

DST /T 18

17, 3/7

46,XY

N,XY

18

24

DST /T 18

19, 1/7

69,XXY

Triploidy, XXY

19

35

TST/DS+AMA

16, 1/7

46,XX

N,XX

20

35

TST/DS+AMA

16, 1/7

46,XX

N,XX

21

37

TST/DS+AMA

17

46,XX

N,XX

22

39

TST/DS+AMA

19, 2/7

46,XY

N,XY

23

38

AMA

21, 5/7

46,XY

N,XY

24

37

AMA

23

46,XX

N,XX

25

37

AMA

22, 5/7

46,XY

N,XY

26

36

AMA

19

46,XY

N,XY

27

41

AMA

17, 3/7

46,XY

N,XY

28

35

AMA

18, 1/7

Culture Failure

N,XY

29

37

AMA

20, 4/7

46,XX

N,XX

30

37

AMA

19, 1/7

Culture Failure

N,XX

31

37

AMA

16, 5/7

46,XX

N,XX

32

41

DS History of prior child

22, 4/7

46,XX

N,XX

33

31

DS History of prior child

16, 6/7

46,XY

N,XY
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Table (continued).
Case No.

Age

Indication

Pregnancy week

Cytogenetic results

FISH results

34

32

IUGR, posterouretral valve

18

46,XY

N,XY

35

26

Oligohydramnios

19

46,XX

N,XX

36

24

IUGR

26

47,XY,+mar/46,XY

N,XY

37

27

Symmetric IUGR

26, 1/7

46,XY

N,XY

38

25

Mass in placenta Cardiac anomaly

29, 6/7

46,XX

N,XX

39
40

27
34

19
23, 2/7

46,XX
46,XY

N,XX
N,XY

41

21

22

46,XX

N,XX

42
43
44
45
46
47
48
49
50

26
31
30
29
30
27
24
35
25

18 1/7
16, 1/7
24
16
26, 4/7
21, 1/7
24
19, 5/7
21, 5/7

46,XY
46,XY
46,XY
46,XX
46,XY
46,XY
47,XX,+18
46, XY
47,XY,+18

N,XY
N,XY
N,XY
N,XX
N,XY
N,XY
Trisomy 18,XX
N,XY
Trisomy 18, XY

51

27

Short femur, polyhydramnios
Increased nuchal translucency,
short femur
Cardiomegaly, pericardial effusion,
nonimmune hydrops
CAM in fetal lungs
Umbilical cyst
Umbilical cyst
IUGR
Mild ventriculomegaly
Early IUGR, mild ventriculomegaly
IUGR, Choroid plexus cyst, renal agenesis
Vermian agenesis
Micrognathia, VSD, choroid plexus
cyst, rocker bottom feet
Renal pyelectasy, complete
atrioventricular septal defect

24

47,XX,+21

Mosaic trisomy
21 (%66)

N: Two signals for chromosome 13, 18, 21 each; AMA: Advanced Maternal Age; TST: Triple Screening Test; DST: Dual Screening Test;
DS: Down Syndrome; IUGR: Intra-Uterine Growth Retardation; CAM: Cystic Adenoid Malformation; VSD: Ventricular Septal Defect

Discussion
Chromosome abnormalities mostly occur together
with congenital abnormalities. They affect intelligence and
usually there is no possible treatment. Given these facts,
prenatal diagnosis of chromosome abnormalities is
important. Despite the fact that standard conventional
cytogenetic methods are indispensable, new techniques
that assist diagnosis, especially those regarding
aneuploidy screening, are used in routine practice today.
Aneuploidy screening by FISH has also become a routine
method in centers that perform prenatal diagnosis (4).
Standard cytogenetic analysis performed on fetal cell
samples identifies chromosome aneuploidies and
rearrangements with approximately 99.5% accuracy.
Yet, the dependence of the method on live and
reproducible cells could be a restraining factor on
chromosome extraction (5). Fetal cells may not adapt
themselves to the environment with a probability of 2%,
and they do not enter mitosis. As a result of long-term
72

cultures, chromosomes can be extracted and analyzed in
7 days at the minimum, and mostly on the 21st day.
Especially in the advanced weeks of pregnancy, families
with abnormal fetuses lose the option to terminate the
pregnancy as the fetus reaches its viability limit.
Studies show that aneuploidies related to
chromosomes 13, 18, 21, X and Y amount to 69%-80%
of all chromosome abnormalities that are identified in the
amniotic fluid (5). Pergament et al. argued that although
chromosome abnormality incidence is 3.4% in cases of
advanced maternal age, when no aneuploidies were
detected for chromosomes 13, 18, 21, X and Y, the
incidence decreases to 0.5% (6). They also showed that
a similar decrease is observed in cases where
abnormalities are identified in fetal USG and DS risk in
screening tests.
The assessment of chromosomes 13, 18, 21, X and Y
for aneuploidy by FISH could be completed in 2 days
following the invasive intervention. This period is
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considerably short when compared to the standard
method. Such an advantage arises from the fact that
interphase nuclei can be examined without the need to
extract the chromosomes. In this respect, the method is
also suggested to families that do not accept a secondary
invasive procedure in cases where culture failure occurs.
In such a case, however, the family should be informed
about the advantages and disadvantages of the method in
a comprehensible way in view of the risky situation. In
our study, cultures that were intended for prenatal
genetic diagnosis due to AMA were not successful and the
chromosomes could not be extracted in 2 cases. The
situation was explained in a second round of genetic
counseling to both families, and the families that did not
accept a second invasive intervention were informed
about aneuploidy screening by FISH. Aneuploidy of any of
the 5 chromosomes was not detected in the fetuses
whose fetal USGs were within the normal limits, and the
pregnancies resulted in healthy births.
DST is used for assessing neural tube defects, DS and
T18, in the first 3 months of pregnancy (7). Thereby, it is
planned to assess the risk in earlier weeks of pregnancy and
to achieve the opportunity for early intervention in cases of
abnormality. However, since most pregnancies that start
with aneuploidy result in spontaneous miscarriage in the
first 3 months of pregnancy, this attempt for early
intervention may become unnecessary. In one of our
patients, in whom we performed aneuploidy screening
upon the risk of T18 in DST, we detected triploidy with
both methods. It should be noted that the increase in T18
risk goes along with triploid pregnancies (8).
TST provides the opportunity for evaluating trisomy
21, trisomy 18 and neural tube defects by means of the
serum samples taken from the mother in the 14th-21st
weeks of pregnancy (9,10). Results for trisomy 21 and
18 are evaluated with 60% accuracy and 5% and 0.4%
false positivity, respectively (10,11). Some 30%-40% of
the fetuses with DS could not be identified in the first and
second trimesters although routine screening tests were
performed. It is noted that fetuses with DS can be
identified at an accuracy rate of 65%-75% and false
positivity rate of 4%-15% by prenatal ultrasonographic
assessments in the second trimester (11). It is obvious
that the combined use of maternal age, the screening test
results and ultrasonographic assessment would yield
more accurate results since it would allow a patientspecific approach.
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In our cases, no DS or T18 was identified in any of the
pregnancies in which DS and T18 risks were detected in
TST. In one case with DS risk, 47, XXY karyotype was
detected (case number 6). It is noted that, in Klinefelter
Syndrome, DS-like results can be obtained by TST (9). In
TST, an increase in beta-HCG level is observed in the
presence of a significant increase in the level of AFP and
vacuolized trophoblasts in oligohydroamniosis (9).
Therefore, detection of the DS risk in TST requires
attention with regard to cases other than aneuploidies
that put the pregnancy at risk.
Although FISH provides results with almost 100%
accuracy for aneuploidy screening, the same method is
insufficient in detecting 25%-30% of cytogenetic
abnormalities that can be identified in routine practice
(12). Only numerical changes in the 5 chromosomes
examined can be determined with this method.
Rearrangements of these chromosomes and numerical
and structural changes in other chromosomes are
excluded from the assessment. Furthermore, decreased
success of direct FISH due to the reduction of the cell
quality in the advanced weeks of pregnancy and especially
due to contamination of the amniotic fluid with maternal
blood is a significant problem faced in practice (13).
In our study, in 1 of the 2 cases in which no
aneuploidy was detected by FISH, mosaic marker
chromosome was identified by the conventional
cytogenetic method, while in the other an increase in the
th
centromeric heterochromatin of the 15 chromosome,
which is considered a normal variant, was identified by
the same method (case number 8 and 36, respectively).
In the first case, it was shown that the variant
chromosome was transferred from the father. The
marker chromosome detected in the second case was
identified as mosaic in similar rates in CS and in the
peripheral blood sample after birth. This pregnancy
th
resulted in premature birth in the 28 week, and the
baby was lost in the 28th day due to necrotizing
enterocolitis, right atrial thrombus, and sepsis.
In cases in which aneuploidy risk is identified by AMA
and screening tests that are applied to the maternal
serum, early diagnosis can be achieved by means of
aneuploidy screening performed with FISH and thereby
families can be assisted in making their decisions as to
whether to continue the pregnancy. However, this
method is inadequate for pregnancies that are at risk due
to other chromosomal diseases in addition to aneuploidy.
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In terms of aneuploidy screening, our research yielded
conformity of 98.03% between the results of the 2
methods. Mosaic trisomy 21 that we detected in case
number 51 by FISH was found to be pure by the
conventional cytogenetic method subsequently.
Moreover, the conventional cytogenetic research
conducted on the skin sample taken after the pregnancy
was terminated upon the decision of the family did not
verify mosaicism. We assumed that the mosaicism
detected with FISH might be either because of the
contamination of the amniotic fluid with maternal blood,
or due to the inadequacy of hybridization resulting from
the failure of the probe to reach the cells with insufficient
quality. Detection of the signals of both the X and Y
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chromosomes in all cells examined after hybridization
with 18, X and Y probes indicates that the situation was
due to hybridization inadequacy specific to the probe
rather than maternal contamination.
Consequently, aneuploidy screening of uncultured
amniotic cells with direct FISH is important for prenatal
diagnosis in pregnancies that have a high risk of
aneuploidy. In cases in which suspicious results are
obtained, examination of the fetus with detailed USG is a
supplementary approach. Since FISH has its own
limitations, it would be more appropriate to use it as a
supplementary method in routine practice along with
conventional cytogenetic methods, rather than viewing it
as a method that can replace the latter.
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